Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in DenmarkLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Ascendis PharmaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 21, 2026, FDA's public records list Ascendis Pharma Bone Diseases A/S with 1 complete response letter. The most recent is a complete response letter dated Apr 28, 2023: Complete response letter, NDA 216490.
Drug approvals, 510(k) clearances, recalls and letters, 2023 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Apr 28, 2023 | Complete response letter, NDA 216490Approved | Complete response letter |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.